budesonide
Alimentary tract and metabolism (A07)US regulatory status: approved. Molecular target: Glucocorticoid receptor.
- Target
- Glucocorticoid receptor
- Mechanism
- Glucocorticoid receptor agonist
pharma · Colitis, Ulcerative
Bausch + Lomb
Bausch + Lomb Ireland Limited
Bausch + Lomb drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Waterford, IE HQ
1853 Founded
167 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Waterford, IE
- Founded
- 1853
- Employees
- 167
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Bausch + Lomb pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Bausch + Lomb drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
US regulatory status: approved. Molecular target: Glucocorticoid receptor.
- Target
- Glucocorticoid receptor
- Mechanism
- Glucocorticoid receptor agonist